SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing significant volatility and aggressive profit-taking, fueling a heated debate among investors about whether this marks a fundamental trend reversal or a healthy correction within the broader semiconductor cycle. While the community remains polarized, many are closely monitoring key support levels to determine if the stock will stabilize or face further downside following its recent parabolic run.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is experiencing significant volatility and trading momentum following a 13G filing revealing that Michael Platts BlueCrest Capital Management has taken a 5.6% stake. The community is actively debating whether this institutional interest signals a sustainable growth phase for the company's humanoid robotics ambitions or if the move is merely a short-term catalyst in an otherwise speculative SPAC environment.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is seeing intense bullish momentum as investors anticipate imminent clinical data on its phase 3 trial, with the community actively discussing a potential short squeeze and M&A speculation heading into a long weekend. The conversation is dominated by high-conviction retail holders who view current volatility as a strategic accumulation opportunity while mocking short sellers for their precarious positioning ahead of expected company news.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&T is experiencing a sharp sell-off driven by speculative fears regarding competition from satellite-based connectivity services and recent regulatory headlines. While the community is actively debating the long-term impact of satellite technology on fiber infrastructure, many investors are viewing the current price as a generational buying opportunity for the company's dividend yield and long-term value.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is drawing intense community focus after reports that it plans to monetize excess AI compute capacity through a new cloud offering, a strategic shift that has sparked heated debate over whether it signals genuine revenue diversification or underlying desperation regarding capital expenditure. Traders are actively clashing over the long-term impact on the AI infrastructure ecosystem, as the stock faces volatile price action driven by conflicting narratives about compute scarcity versus potential overcapacity.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is experiencing significant volatility and heavy trading volume as investors react to a combination of mixed financial results, a strategic $475 million acquisition of Alkira, and the ongoing shift toward AI-driven infrastructure. The community is actively debating the company's long-term potential as a data center connectivity provider, with many bulls highlighting institutional accumulation and potential for a breakout, while others express frustration over management communication, the impact of debt management, and the slow pace of revenue growth inflection.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the Consumer and Business segments. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizon is trending as investors weigh the stock's defensive appeal and high dividend yield against concerns over its significant debt load and the potential competitive threat from SpaceX's Starlink. The community is actively debating the reliability of telecom infrastructure versus emerging satellite alternatives, while positioning themselves ahead of the upcoming earnings release.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is facing intense investor backlash driven by a massive stock grant for its co-CEOs and ongoing concerns over high dilution, leading to a sharp selloff. Despite the negativity, some community members view the current price level as a potential bottom and remain focused on the company's long-term infrastructure and power-scaling thesis.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is currently experiencing significant volatility and retail frustration as shareholders debate whether the stock is a long-term quantum infrastructure play being suppressed by institutional manipulation or a failing 'pump-and-dump' scheme following recent analyst upgrades and insider selling. Despite active community discussion regarding government contracts and technical potential, the price action remains range-bound, leading to a polarized battle between those advocating for long-term accumulation and others pointing to negative price momentum as a signal to exit.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is facing intense volatility as the stock experiences a sharp, sector-wide sell-off that the community is actively debating as either a fundamental breakdown or a temporary liquidity reset. While some investors are aggressively buying the dip on the belief that demand for optical infrastructure remains intact, others are warning of further technical deterioration and downward pressure as the stock struggles to find a stable support floor.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

OTLK Stock Up 35% as FDA Accepts Resubmitted Eye Drug BLA for Review

Outlook Therapeutics stock surges 35% after the FDA accepts the resubmitted Lytenava BLA for wet AMD for review, setting a July 29, 2026, decision date.

Outlook Therapeutics Eye Drug Review Returns To FDA For Fourth Time

Outlook Therapeutics shares rose after the FDA accepted its resubmitted LYTENAVA BLA and set a July 2026 target action date.read more...

OTLK Stock Soars 28% After FDA Sets July Date For Lytenava Decision

Equity

The agency will now decide whether to approve the drug by July 29, 2026.

OTLK Stock Surges On FDA Lytenava Application Resubmission After Successful Appeal  

A decision on the resubmitted application is expected within 60 days of the FDA’s receipt of it, the company said.


OTLK Stock Rocket Nearly 140%: Lytenava Dispute Resolution With FDA Pushes Stock On Track For Best Week On Record

Outlook Therapeutics wins appeal following formal dispute resolution process for LYTENAVA.

Why RDW, TE, OTLK Stocks Posted Double-Digit Gains On Tuesday

Redwire, T1 Energy, and Outlook Therapeutics shares soared due to broad sectoral optimism, strong institutional backing, and positive company developments, respectively. 

Traders Rush into AI, Biotech, and Emerging Tech

Momentum traders are aggressively rotating into AI infrastructure, biotech catalysts, blockchain exposure, and emerging technology plays as speculative appetite continues heating up across small-cap and high-growth sectors. $KBLB, $OTLK, $PHGE, $UZX, $QTEK $ARTL, $VCIG, $YMAT, $NCRA

Outlook Therapeutics Stock Climbs 38% After Winning FDA Appeal For NAMD Therapy

(RTTNews) - Shares of Outlook Therapeutics, Inc. (OTLK) are climbing about 38 percent in Tuesday morning trading after the company announced that the U.S. FDA has granted its appeal following completion of the Formal Dispute Resolution process for ONS-5010/LYTENAVA, its investiga...

OTLK Stock Surges Over 50% Pre-Market, Breaches Key Technical Milestone – What’s Behind This Massive Rally?

The U.S. Food and Drug Administration granted Outlook Therapeutics its appeal following a formal dispute resolution process related to its eye disease drug Lytenava.

Oncobiologics, Inc. (OTLK) Reports Q2 Loss, Lags Revenue Estimates

Oncobiologics (OTLK) delivered earnings and revenue surprises of -33.33% and -97.09%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

This account has been verified as an official OTLK representative.

Verified Account

Outlook Therapeutics

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.

Outlook Therapeutics Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$1.45
Prev Close	$1.47
Open	$1.50
Dividend Yield	0.00%
50-Day Moving Average	$0.7325
Beta	0.77
Avg. Volume	19.15M
PE Ratio	-1.35

52-Week High	$3.39
52-Week Low	$0.1611
Market Capitalization	$235.42M
EPS (Annual)	-$1.79
Price to Book	-5.30
Revenue Per Employee	$83,149.12

Feed

News

Sentiment

Earnings

Fundamentals

Info

OTLKOutlook Therapeutics Inc

Latest OTLK News